{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T11:15:52Z","timestamp":1795173352540,"version":"4.10.3"},"reference-count":176,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2004,12,15]]},"abstract":"<jats:p>Germline inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene causes the von Hippel-Lindau hereditary cancer syndrome, and somatic mutations of this gene have been linked to the development of sporadic hemangioblastomas and clear-cell renal carcinomas. The VHL tumor suppressor protein (pVHL), through its oxygen-dependent polyubiquitylation of hypoxia-inducible factor (HIF), plays a central role in the mammalian oxygen-sensing pathway. This interaction between pVHL and HIF is governed by post-translational prolyl hydroxylation of HIF in the presence of oxygen by a conserved family of Egl-nine (EGLN) enzymes. In the absence of pVHL, HIF becomes stabilized and is free to induce the expression of its target genes, many of which are important in regulating angiogenesis, cell growth, or cell survival. Moreover, preliminary data indicate that HIF plays a critical role in pVHL-defective tumor formation, raising the possibility that drugs directed against HIF or its downstream targets (such as vascular endothelial growth factor) might one day play a role in the treatment of hemangioblastoma and renal cell carcinoma. On the other hand, clear genotype-phenotype correlations are emerging in VHL disease and can be rationalized if pVHL has functions separate from its control of HIF.<\/jats:p>","DOI":"10.1200\/jco.2004.05.061","type":"journal-article","created":{"date-parts":[[2004,12,20]],"date-time":"2004-12-20T22:02:26Z","timestamp":1103580146000},"page":"4991-5004","source":"Crossref","is-referenced-by-count":814,"title":["Role of\n                    <i>VHL<\/i>\n                    Gene Mutation in Human Cancer"],"prefix":"10.1200","volume":"22","author":[{"given":"William Y.","family":"Kim","sequence":"first","affiliation":[{"name":"From the Howard Hughes Medical Institute, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Kaelin","sequence":"additional","affiliation":[{"name":"From the Howard Hughes Medical Institute, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","unstructured":"Collins E: Intra-ocular growths (two cases, brother and sister, with peculiar vascular new growth, probably retinal, affecting both eyes). Trans Ophthalmol Soc U K 14:141,1894-149,"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01994821"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Lindau A: Zur frage der angiomatosis retinai und ihrer hirncomplikation. Acta Ophthalmol 4:193,1927-226,","DOI":"10.1111\/j.1755-3768.1926.tb07786.x"},{"key":"R4","unstructured":"Davison C, Brock S, Cyke CG: Retinal and central nervous hemangioblastomatosis with visceral changes (von Hippel-Lindau's disease). Bull Neurol Inst New York 5:72,1936-93,"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199711000-00001"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1038\/332268a0"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1126\/science.8493574"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1007\/s004390050281"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1038\/nm0895-822"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/5.5.639"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1002\/humu.1380050109"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1038\/ng0597-68"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1038\/ng849"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00104-6"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200212000-00002"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)61751-5"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/11.20.2347"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1126\/science.287.5454.848"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1270"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020152"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1038\/ng0594-85"},{"key":"R24","unstructured":"Whaley JM, Naglich J, Gelbert L, et al: Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 55:1092,1994-1102,"},{"key":"R25","unstructured":"Lee JY, Dong SM, Park WS, et al: Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res 58:504,1998-508,"},{"key":"R26","unstructured":"Shuin T, Kondo K, Torigoe S, et al: Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54:2852,1994-2855,"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/3.12.2169"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199606)179:2<157::AID-PATH557>3.0.CO;2-S"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1999)13:6<464::AID-HUMU6>3.0.CO;2-A"},{"key":"R30","unstructured":"Brauch H, Weirich G, Brieger J, et al: VHL alterations in human clear cell renal cell carcinoma: Association with advanced tumor stage and a novel hot spot mutation. Cancer Res 60:1942,2000-1948,"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.10054"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10635"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)69132-8"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.21.9700"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1007\/s002920050109"},{"key":"R37","unstructured":"Kanno H, Kondo K, Ito S, et al: Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:4845,1994-4847,"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199606)179:2<151::AID-PATH556>3.0.CO;2-0"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/107.4.459"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<424::AID-HUMU9>3.0.CO;2-H"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.70.5.644"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2002.97.4.0977"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1076\/opge.23.1.21.2201"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90127-6"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.3251150.x"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.32.12.934"},{"key":"R47","doi-asserted-by":"crossref","unstructured":"Hofstra RM, Stelwagen T, Stulp RP, et al: Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases. J Clin Endocrinol Metab 81:2881,1996-2884,","DOI":"10.1210\/jc.81.8.2881"},{"key":"R48","doi-asserted-by":"crossref","unstructured":"Brauch H, Hoeppner W, Jahnig H, et al: Sporadic pheochromocytomas are rarely associated with germline mutations in the VHL tumor suppressor gene or the ret protooncogene. J Clin Endocrinol Metab 82:4101,1997-4104,","DOI":"10.1210\/jc.82.12.4101"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<337::AID-IJC5>3.0.CO;2-P"},{"key":"R50","doi-asserted-by":"crossref","unstructured":"Bender BU, Gutsche M, Glasker S, et al: Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas. J Clin Endocrinol Metab 85:4568,2000-4574,","DOI":"10.1210\/jc.85.12.4568"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11060"},{"key":"R52","unstructured":"Knudson AG Jr, Strong LC, Anderson DE: Heredity and cancer in man. Prog Med Genet 9:113,1973-158,"},{"key":"R53","doi-asserted-by":"crossref","unstructured":"Foster K, Osborne RJ, Huddart RA, et al: Molecular genetic analysis of the von Hippel-Lindau disease (VHL) tumour suppressor gene in gonadal tumours. Eur J Cancer 31A:2392,1995-2395,","DOI":"10.1016\/0959-8049(95)00437-8"},{"key":"R54","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(96)90368-8"},{"key":"R55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.15.8817"},{"key":"R56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.20.11661"},{"key":"R57","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202473"},{"key":"R58","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(1998)78:11+<62::AID-IJC17>3.0.CO;2-V"},{"key":"R59","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.5.1770"},{"key":"R60","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.2.1486"},{"key":"R61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.14.6459"},{"key":"R62","doi-asserted-by":"publisher","DOI":"10.1038\/ncb899"},{"key":"R63","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199605000-00004"},{"key":"R64","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65541-1"},{"key":"R65","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.1885"},{"key":"R66","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199711000-00009"},{"key":"R67","unstructured":"Wizigmann-Voos S, Breier G, Risau W, et al: Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 55:1358,1995-1364,"},{"key":"R68","unstructured":"Takahashi A, Sasaki H, Kim SJ, et al: Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 54:4233,1994-4237,"},{"key":"R69","unstructured":"Brown LF, Berse B, Jackman RW, et al: Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143:1255,1993-1262,"},{"key":"R70","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-197708000-00017"},{"key":"R71","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V49.3.399.bloodjournal493399"},{"key":"R72","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.3.356"},{"key":"R73","doi-asserted-by":"publisher","DOI":"10.1007\/BF01632856"},{"key":"R74","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203938"},{"key":"R75","unstructured":"Siemeister G, Weindel K, Mohrs K, et al: Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res 56:2299,1996-2301,"},{"key":"R76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.20.10589"},{"key":"R77","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.20.10595"},{"key":"R78","unstructured":"Kishida T, Stackhouse TM, Chen F, et al: Cellular proteins that bind the von Hippel-Lindau disease gene product: Mapping of binding domains and the effect of missense mutations. Cancer Res 55:4544,1995-4548,"},{"key":"R79","doi-asserted-by":"publisher","DOI":"10.1126\/science.7660130"},{"key":"R80","doi-asserted-by":"publisher","DOI":"10.1126\/science.7660122"},{"key":"R81","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.6.2156"},{"key":"R82","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.2.732"},{"key":"R83","doi-asserted-by":"publisher","DOI":"10.1101\/gad.13.22.2928"},{"key":"R84","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80098-7"},{"key":"R85","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.15.1.435"},{"key":"R86","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5413.455"},{"key":"R87","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.22.12436"},{"key":"R88","doi-asserted-by":"publisher","DOI":"10.1101\/gad.13.14.1822"},{"key":"R89","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(00)00194-0"},{"key":"R90","doi-asserted-by":"publisher","DOI":"10.1038\/20459"},{"key":"R91","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.190332597"},{"key":"R92","doi-asserted-by":"publisher","DOI":"10.1038\/35017054"},{"key":"R93","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/19.16.4298"},{"key":"R94","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M002740200"},{"key":"R95","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.17.11205"},{"key":"R96","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.10.6519"},{"key":"R97","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.14.7987"},{"key":"R98","doi-asserted-by":"publisher","DOI":"10.1126\/science.1059817"},{"key":"R99","doi-asserted-by":"publisher","DOI":"10.1126\/science.1059796"},{"key":"R100","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.181341498"},{"key":"R101","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.18.5197"},{"key":"R102","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208681200"},{"key":"R103","doi-asserted-by":"publisher","DOI":"10.1126\/science.1073440"},{"key":"R104","doi-asserted-by":"publisher","DOI":"10.1038\/nature00767"},{"key":"R105","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00507-4"},{"key":"R106","doi-asserted-by":"publisher","DOI":"10.1126\/science.1066373"},{"key":"R107","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192342099"},{"key":"R108","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(01)00633-3"},{"key":"R109","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.22.6573"},{"key":"R110","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.7.1905"},{"key":"R111","doi-asserted-by":"publisher","DOI":"10.1101\/gad.991402"},{"key":"R112","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068592"},{"key":"R113","doi-asserted-by":"publisher","DOI":"10.1101\/gad.924501"},{"key":"R114","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.9.2984-2992.2002"},{"key":"R115","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1013"},{"key":"R116","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(76)80052-4"},{"key":"R117","doi-asserted-by":"publisher","DOI":"10.1063\/1.1303764"},{"key":"R118","doi-asserted-by":"crossref","unstructured":"Aravind L, Koonin EV: The DNA-repair protein ALKLK, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases. Genome Biol 2:research0007.1,2001-0007.8,","DOI":"10.1186\/gb-2001-2-3-research0007"},{"key":"R119","doi-asserted-by":"publisher","DOI":"10.1086\/324413"},{"key":"R120","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020525"},{"key":"R121","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/10.10.1019"},{"key":"R122","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1843"},{"key":"R123","doi-asserted-by":"publisher","DOI":"10.1038\/ng1019"},{"key":"R124","doi-asserted-by":"publisher","DOI":"10.1101\/gad.914801"},{"key":"R125","doi-asserted-by":"publisher","DOI":"10.1038\/nm1202-795"},{"key":"R126","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.18.2255"},{"key":"R127","unstructured":"Jiang Y, Zhang W, Kondo K, et al: Gene Expression Profiling in a Renal Cell Carcinoma Cell Line: Dissecting VHL and Hypoxia-Dependent Pathways. Mol Cancer Res 1:453,2003-462,"},{"key":"R128","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204012"},{"key":"R129","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M107880200"},{"key":"R130","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.41.26277"},{"key":"R131","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.1347"},{"key":"R132","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M909970199"},{"key":"R133","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)00534-X"},{"key":"R134","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M108269200"},{"key":"R135","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0436037100"},{"key":"R136","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M205040200"},{"key":"R137","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg173"},{"key":"R138","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)80096-9"},{"key":"R139","unstructured":"Lieubeau-Teillet B, Rak J, Jothy S, et al: Von Hippel-Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids. Cancer Res 58:4957,1998-4962,"},{"key":"R140","unstructured":"Esteban-Barragan MA, Avila P, Alvarez-Tejado M, et al: Role of the von Hippel-Lindau tumor suppressor gene in the formation of beta1-integrin fibrillar adhesions. Cancer Res 62:2929,2002-2936,"},{"key":"R141","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.9.5902"},{"key":"R142","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.21.3.865-874.2001"},{"key":"R143","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.3.993"},{"key":"R144","unstructured":"Bindra RS, Vasselli JR, Stearman R, et al: VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells. Cancer Res 62:3014,2002-3019,"},{"key":"R145","unstructured":"Zatyka M, da Silva NF, Clifford SC, et al: Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease. Cancer Res 62:3803,2002-3811,"},{"key":"R146","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M305502200"},{"key":"R147","doi-asserted-by":"crossref","unstructured":"de Paulsen N, Brychzy A, Fournier MC, et al: Role of transforming growth factor-alpha in von Hippel\u2013Lindau (VHL)(-\/-) clear cell renal carcinoma cell proliferation: A possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis. Proc Natl Acad Sci U S A 98:1387,2001-1392,","DOI":"10.1073\/pnas.031587498"},{"key":"R148","unstructured":"Knebelmann B, Ananth S, Cohen HT, et al: Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor. Cancer Res 58:226,1998-231,"},{"key":"R149","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.17.9102"},{"key":"R150","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.4.1583"},{"key":"R151","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W"},{"key":"R152","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(97)90075-7"},{"key":"R153","unstructured":"Reifenberger G, Reifenberger J, Bilzer T, et al: Coexpression of transforming growth factor-alpha and epidermal growth factor receptor in capillary hemangioblastomas of the central nervous system. Am J Pathol 147:245,1995-250,"},{"key":"R154","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.16.8761"},{"key":"R155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0000083"},{"key":"R156","doi-asserted-by":"crossref","unstructured":"Zimmer M, Doucette D, Siddiqui N, et al: Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL\u2212\/\u2212 tumors. Mol Cancer Res 2:89,2004-95,","DOI":"10.1158\/1541-7786.89.2.2"},{"key":"R157","doi-asserted-by":"publisher","DOI":"10.2174\/1389450033346885"},{"key":"R158","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01159-4"},{"key":"R159","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.10.3851"},{"key":"R160","unstructured":"Rogers LR, Kaelin W, Nadler P, et al: Response of cerebellar hemangioblastomas associated with von Hippel-Lindau disease to OSI-774 (Tarceva\u2122). Proc Am Soc Clin Oncol 21:75b,2002, (abstr 2111)"},{"key":"R161","unstructured":"Fabbro D, Garcia-Echeverria C: Targeting protein kinases in cancer therapy. Curr Opin Drug Discov Devel 5:701,2002-712,"},{"key":"R162","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00071-5"},{"key":"R163","unstructured":"Lubensky IA, Gnarra JR, Bertheau P, et al: Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients. Am J Pathol 149:2089,1996-2094,"},{"key":"R164","unstructured":"Zhuang Z, Roth MJ, Emmert-Buck MR, et al: Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction. Acta Cytol 38:671,1994-675,"},{"key":"R165","unstructured":"Zhuang Z, Gnarra JR, Dudley CF, et al: Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens. Mod Pathol 9:838,1996-842,"},{"key":"R166","unstructured":"Wiesener MS, Munchenhagen PM, Berger I, et al: Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Cancer Res 61:5215,2001-5222,"},{"key":"R167","unstructured":"Mydlo JH, Michaeli J, Cordon-Cardo C, et al: Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. Cancer Res 49:3407,1989-3411,"},{"key":"R168","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00043-0"},{"key":"R169","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00044-2"},{"key":"R170","unstructured":"Drevs J, Hofmann I, Hugenschmidt H, et al: Effects of PTK787\/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. Cancer Res 60:4819,2000-4824,"},{"key":"R171","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021491"},{"key":"R172","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/10.10.1029"},{"key":"R173","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.21.3320"},{"key":"R174","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.01696.x"},{"key":"R175","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.42.30109"},{"key":"R176","unstructured":"Bauer AL, Paulding WR, Striet JB, et al: Endogenous von Hippel-Lindau tumor suppressor protein regulates catecholaminergic phenotype in PC12 cells. Cancer Res 62:1682,2002-1687,"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2004.05.061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T20:32:17Z","timestamp":1682886737000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2004.05.061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,15]]},"references-count":176,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2004,12,15]]}},"alternative-id":["10.1200\/JCO.2004.05.061"],"URL":"https:\/\/doi.org\/10.1200\/jco.2004.05.061","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,15]]}}}